Successful treatment of refractory bleeding with recombinant factor VIIa after redo coronary artery bypass graft surgery.
von Heymann
Christian
C
Department of Anesthesiology, University Hospital Charité Campus Mitte, Berlin, Germany. christian.von_heymann@charite.de
Hotz
H
H
Konertz
W
W
Kox
W J
WJ
Spies
C
C
D000368:Aged; D001026:Coronary Artery Bypass; D015942:Factor VIIa / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D019106:Postoperative Hemorrhage / Q000188:drug therapy*; D011994:Recombinant Proteins / Q000627:therapeutic use; D012086:Reoperation
D011994:Recombinant Proteins; D015942:Factor VIIa